Access and Reimbursement in Germany

agregó una foto Lançamentos & Anúncios

2026-10-01 05:16:14 -

Access to CAR T cell therapy in Germany is shaped by the country's healthcare system, regulatory framework, and reimbursement policies. Germany has a universal healthcare system with statutory and private insurance, and coverage decisions are made based on evidence of benefit. For CAR T cell therapy, which is expensive and complex, reimbursement is a critical factor in patient access. The...

0 Commentarios 0 Acciones 0 Vista previa